Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31882
Title: Short sleep duration is associated with lower cerebrospinal fluid amyloid beta 42 levels in midlife: A preliminary report.
Austin Authors: Gibson, Madeline;Nicolazzo, Jessica;Cavuoto, Marina;Rowsthorn, Ella;Cribb, Lachlan;Bransby, Lisa;Buckley, Rachel;Yassi, Nawaf;Yiallourou, Stephanie;Brodtmann, Amy ;Velakoulis, Dennis;Eratne, Dhamidhu;Hamilton, Garun S;Naughton, Matthew T;Lim, Yen Ying;Pase, Matthew P
Affiliation: The Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.
Neurology
Melbourne School of Psychological Sciences, University of Melbourne, Parkville, Victoria, Australia.
Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
Neuropsychiatry at The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Monash Lung, Sleep, Allergy and Immunology, Monash Health, Clayton, Australia.
Department of Respiratory Medicine, Alfred Health and Central Clinical.
Issue Date: 12-Apr-2023
Date: 2022
Publication information: Sleep 2023; 46(4)
URI: https://ahro.austin.org.au/austinjspui/handle/1/31882
DOI: 10.1093/sleep/zsac307
ORCID: 0000-0002-8102-2775
0000-0001-5044-0766
0000-0002-5356-5537
Journal: Sleep
PubMed URL: 36534943
ISSN: 1550-9109
Type: Journal Article
Subjects: Alzheimer’s disease
amyloid
biomarkers
cerebrospinal fluid
sleep
sleep duration
Appears in Collections:Journal articles

Show full item record

Page view(s)

44
checked on Dec 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.